GoodRx Holdings (GDRX) Equity Ratio (2019 - 2026)

GoodRx Holdings' Equity Ratio history runs 8 years deep, the most recent figure standing at 0.31 for Q1 2026.

• In Q1 2026, Equity Ratio fell 39.09% year-over-year to 0.31; the TTM figure through Mar 2026 stood at 0.31 (down 39.09% YoY), while the FY2025 annual figure was 0.44, down 15.93% from the prior year.
• Equity Ratio came in at 0.31 for Q1 2026 at GoodRx Holdings, down from 0.44 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.53 in Q2 2023 to a low of 0.31 in Q1 2026.
• A 5-year average of 0.48 and a median of 0.51 in 2025 frame the typical range for Equity Ratio.
• Across the five-year window, Equity Ratio advanced 16.39% in 2025 and plunged 39.09% in 2026, its largest moves.
• GoodRx Holdings' Equity Ratio stood at 0.51 in 2022, then decreased by 5.56% to 0.48 in 2023, then increased by 8.86% to 0.52 in 2024, then slipped by 15.93% to 0.44 in 2025, then dropped by 29.89% to 0.31 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.31, 0.44, and 0.45 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison